+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Moxifloxacin"

DNA gyrase inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

DNA gyrase inhibitors - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
From
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Moxifloxacin is an antibiotic used in the treatment of oncology drugs. It is a fourth-generation fluoroquinolone, which is a type of antibiotic that works by inhibiting bacterial DNA replication. Moxifloxacin is used to treat a variety of infections, including those caused by bacteria, viruses, and fungi. It is also used to treat certain types of cancer, such as leukemia and lymphoma. Moxifloxacin is generally well-tolerated and has few side effects. Moxifloxacin is available in both oral and intravenous formulations. It is typically prescribed for short-term use, as long-term use can lead to the development of antibiotic resistance. The drug is also used in combination with other drugs to treat certain types of cancer. The moxifloxacin market is highly competitive, with several companies offering the drug. Some of the major players in the market include Pfizer, Merck, Novartis, and AstraZeneca. Show Less Read more